DKK1 and lung carcinoma: Further results showed that there was an obvious elevation of Dkk-1 in HBMECs compared to that of HUVEC under lung cancer cell-derived exosomes treatment, suggesting that the release of Dkk-1 in the progress displayed an organtropic pattern (Figures 2D,E).